Product/Composition:- | Tramadol + Paracetamol tablets |
---|---|
Strength:- | 37.5 mg tramadol + 325 mg paracetamol; 75 mg + 650 mg |
Form:- | Oral Tablets |
Reference Brands:- | Ultracet(US); Tramacet(EU) |
MOQ | As per the manufacturer batch size |
Get Quote Send Enquiry on WhatsApp |
Tramadol + Paracetamol tablets combine tramadol’s action as a weak opioid agonist and serotonin reuptake inhibitor with paracetamol’s inhibition of prostaglandin synthesis. This dual mechanism provides effective relief from moderate to severe pain, offering rapid onset, improved analgesia, and reduced opioid dose when used responsibly under medical supervision.
Tramadol + Paracetamol tablets are approved in the EU and US for moderate to severe pain management. In the EU, brands like Tramacet are regulated by EMA, supported by dossiers demonstrating safety, efficacy, and manufacturing standards. In the US, FDA approval relies on extensive clinical data; generic options are also available. Both regions enforce strict regulations, including proper labeling and usage guidelines, due to potential dependence and misuse risks. For expert assistance with regulatory dossiers, compliance, and registration, visit PharmaTradz. We support seamless market access for tramadol + paracetamol formulations, ensuring adherence to European and US standards for safe, effective analgesic therapy.